Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$6.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 14 most recent Form 4 transactions.
| May 18 | ZBIO | Zenas BioPharma, Inc. | PBUY | 60,000 | $16.88 | $1M | +162.5% | Open the original filing on SEC.gov |
| Apr 29 | ZBIO | Zenas BioPharma, Inc. | PBUY | 35,000 | $17.62 | $616.7K | +2.0% | Open the original filing on SEC.gov |
| Apr 28 | ZBIO | Zenas BioPharma, Inc. | PBUY | 25,000 | $18.02 | $450.5K | +1.5% | Open the original filing on SEC.gov |
| Mar 31 | ZBIO | Zenas BioPharma, Inc. | PBUY | 34,000 | $19.31 | $656.5K | +2.0% | Open the original filing on SEC.gov |
| Mar 30 | ZBIO | Zenas BioPharma, Inc. | PBUY | 20,000 | $18.23 | $364.6K | +1.2% | Open the original filing on SEC.gov |
| Feb 2 | ZBIO | Zenas BioPharma, Inc. | PBUY | 57,000 | $17.96 | $1M | +15.6% | Open the original filing on SEC.gov |
| Jan 9 | ZBIO | Zenas BioPharma, Inc. | PBUY | 20,000 | $16.55 | $331K | +5.8% | Open the original filing on SEC.gov |
| Jan 8 | ZBIO | Zenas BioPharma, Inc. | PBUY | 30,000 | $16.30 | $489K | +9.5% | Open the original filing on SEC.gov |
| Jan 7 | ZBIO | Zenas BioPharma, Inc. | PBUY | 50,000 | $16.38 | $819K | +18.8% | Open the original filing on SEC.gov |
| Oct 7, 2025 | ZBIO | Zenas BioPharma, Inc. | PBUY | 36,928 | $20.85 | $769.9K | — | Open the original filing on SEC.gov |
| Jun 18, 2025 | ZLAB | Zai Lab Ltd | AGRANT | 10,831 | — | — | +17.5% | Open the original filing on SEC.gov |
| Jun 10, 2025 | ZBIO | Zenas BioPharma, Inc. | AGRANT◆ | 400,000 | — | — | — | Open the original filing on SEC.gov |